Abstract
The treatment of later-onset Pompe disease with enzyme replacement therapy may not lead to significant improvement in muscle function, probably because of the irreversible muscle destruction caused by glycogen storage. A prospective study was performed to understand early muscle pathology in patients and the response of these pathologic changes to treatment. Five newborns and one child with later-onset Pompe disease but no signs at time of diagnosis were prospectively followed, and treatment was initiated when signs appeared. Six pretreatment biopsies taken at ages 1.5 months to 7 years indicated glycogen storage, lipid storage, stage 4 myocytes, and autophagic debris. Four 6-month posttreatment biopsies revealed glycogen clearance, but stage 4 myocytes and autophagic debris were still evident in three. In conclusion, among patients with later-onset Pompe disease and very mild signs, advanced pathologic changes were evident in a small portion of their myocytes. Because these pathologic changes may not respond to treatment, early treatment is necessary to achieve the best outcomes.
References
Jan 8, 2005·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Colleen M LynchBeth L Thurberg
Sep 1, 2005·Journal of Neurology·Léon P F WinkelAns T van der Ploeg
Mar 1, 2006·Neurology·M L C HagemansA T Van der Ploeg
Dec 8, 2006·Neurology·P S KishnaniJ E Wraith
Jul 24, 2007·Neuromuscular Disorders : NMD·Wolfgang Müller-FelberBenedikt Schoser
May 30, 2008·Neuromuscular Disorders : NMD·C I van CapelleA T van der Ploeg
Jun 4, 2008·Pediatrics·Yin-Hsiu ChienWuh-Liang Hwu
Sep 26, 2008·Muscle & Nerve·John H J WokkePascal Laforet
Oct 22, 2008·Molecular Genetics and Metabolism·Laura E CasePriya S Kishnani
Nov 13, 2008·Autophagy·Nina RabenPaul Plotz
Mar 17, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Marc NicolinoPriya S Kishnani
May 29, 2009·Proceedings of the National Academy of Sciences of the United States of America·Lara R DeRuisseauBarry J Byrne
Aug 4, 2009·Journal of Neurology·S StrothotteBenedikt Schoser
Sep 25, 2009·Molecular Genetics and Metabolism·Priya S KishnaniY-T Chen
Dec 2, 2009·Pediatrics·Yin-Hsiu ChienWuh-Liang Hwu
Aug 31, 2010·Molecular Genetics and Metabolism·Nina RabenPaul H Plotz
Sep 8, 2010·Journal of Inherited Metabolic Disease·Mohamed A HamdanMohamed H Almalik
Jan 15, 2011·The Journal of Pediatrics·Yin-Hsiu ChienWuh-Liang Hwu
Citations
Feb 5, 2013·Journal of Biomedical Optics·Wenhua LiuEvelyn Ralston
Mar 5, 2013·FEBS Letters·Spyros P BatziosEleni Papakonstantinou
Jan 5, 2014·Acta Neuropathologica Communications·Erin J FeeneyNina Raben
May 18, 2016·Orphanet Journal of Rare Diseases·Steven Shinn-Forng PengYin-Hsiu Chien
Oct 30, 2016·Neuromuscular Disorders : NMD·Olcay ÜnverDilşad Türkdoğan
Sep 24, 2019·Neuropathology and Applied Neurobiology·M KulessaA Schänzer
Nov 12, 2019·Journal of Inherited Metabolic Disease·Aleena A KhanPriya S Kishnani
Sep 22, 2017·Diseases·Joaquin Bobillo LobatoLuis M Jiménez Jiménez
Jan 22, 2021·JIMD Reports·Samuela A FernandesPriya S Kishnani